What is the registration number for ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV?

ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV is registered under USPTO registration number 0.

ANV

USPTO Trademark Record

ABANDONED

ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV

Q: Who owns the ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV trademark?

The ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV trademark is owned by Bristol-Myers Squibb Company.

Q: What class is the ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV trademark registered in?

The ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV?

The USPTO serial number for ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV is 85354242.

SN 85354242·Reg 0·Filed Jun 23, 2011

Owner Bristol-Myers Squibb Company

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV (Serial No. 85354242), Registration No. 0, is a abandoned US trademark filed on Jun 23, 2011 by Bristol-Myers Squibb Company. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV (Reg. #0) is an abandoned US trademark that was filed in 2011 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 23, 2011

SERIAL

85354242

REG#

Owner

Applicant

Bristol-Myers Squibb Company

Entity

Corporation

State

Address

345 Park Avenue, New York, NY, 10154

Country

Attorney

NameMarilyn Kelly

Law firm

Marilyn F. Kelly BRISTOL-MYERS SQUIBB COMPANY

Address

P.O. BOX 4000, TRADEMARKS DEPT. - MAILSTOP D33-05, PRINCETON, NJ 08648-4000, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJun 23, 2011

Serial Number85354242

Registration No.0

Status DateAug 26, 2013

Published for OppositionMay 29, 2012

Mark TypeStandard characters

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2011

YEARS AGO

15y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

22 events

ABANDONMENT - NO USE STATEMENT FILED

Aug 26, 2013

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Aug 26, 2013

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 12, 2013

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

Jan 26, 2013

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 25, 2013

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 GRANTED

Jan 25, 2013

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Jan 10, 2013

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jan 10, 2013

SOU EXTENSION 1 FILED

NOA MAILED - SOU REQUIRED FROM APPLICANT

Jul 24, 2012

NOA MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 29, 2012

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

May 09, 2012

NOTICE OF PUBLICATION

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 21, 2012

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Apr 21, 2012

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 29, 2012

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 29, 2012

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 29, 2012

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 29, 2012

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION MAILED

Oct 06, 2011

NON-FINAL ACTION MAILED

NON-FINAL ACTION WRITTEN

Oct 05, 2011

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 16, 2011

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 29, 2011

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 27, 2011

NEW APPLICATION ENTERED

ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Bristol-Myers Squibb Company

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Marilyn Kelly

Resources

Company